Researchers continue to seek innovative therapeutic approaches for new cancer treatments and have turned their attention to snake venoms. Albeit an unexpected source, venoms consist of complex mixtures containing various bioactive molecules that have shown potential in drug discovery. This intricate composition allows molecules to recognize biological targets, paving the way for anti-cancer drug development.
This discovery is not new, as the usage of snake venoms in cancer therapy was explored in the 1930s, with early trials showing mixed results. Research on using snake venoms in cancer therapy has since progressed. Recent studies focus on advancing structure elucidation, positioning snake venom compounds as promising candidates for targeted cancer therapy.
